chr12-53503101-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_134323.2(TARBP2):c.298A>G(p.Met100Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000143 in 1,398,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_134323.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000129 AC: 2AN: 155078Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 81684
GnomAD4 exome AF: 0.00000143 AC: 2AN: 1398256Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 689734
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.298A>G (p.M100V) alteration is located in exon 3 (coding exon 3) of the TARBP2 gene. This alteration results from a A to G substitution at nucleotide position 298, causing the methionine (M) at amino acid position 100 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at